key: cord-0981572-rdtbbvmz
authors: Fernandez, Claire E.; Franz, Colin K.; Ko, Jason H.; Walter, James M.; Koralnik, Igor J.; Ahlawat, Shivani; Deshmukh, Swati
title: Imaging Review of Peripheral Nerve Injuries in Patients with COVID-19
date: 2020-12-01
journal: Radiology
DOI: 10.1148/radiol.2020203116
sha: 736be8284805e70ebc42d5416dc9d9ea348e1e85
doc_id: 981572
cord_uid: rdtbbvmz

With surging numbers of coronavirus disease 2019 (COVID-19) patients throughout the world, neuromuscular complications and rehabilitation concerns are becoming more apparent. Peripheral nerve injury can occur in COVID-19 patients secondary to post-infectious inflammatory neuropathy, prone positioning-related stretch/compression injury, systemic neuropathy, or nerve entrapment from hematoma. Imaging of peripheral nerves in COVID-19 patients may help characterize nerve pathology, identify site and severity of nerve damage, and potentially elucidate mechanisms of injury thereby aiding the medical diagnosis and decisionmaking process. This review article aims to provide a first comprehensive summary of the current knowledge of COVID-19 and peripheral nerve imaging.

and quickly spread across the world, with the World Health Organization officially declaring it as a pandemic on March 11 th 2020. While the respiratory system is primarily affected in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, neurological complications affecting both the central and peripheral nervous systems have been reported (1) (2) (3) . An observational investigation of 214 patients with COVID-19 reported peripheral nervous system involvement in up to 8.9 % of people (4) . As the number of COVID-19 survivors surges, longterm sequela and rehabilitation concerns related to neuromuscular pathology are becoming more apparent (2, 3) .

While mechanisms of COVID-19-related neuropathy are yet to be fully understood, the receptor for SARS-CoV-2 (angiotensin converting enzyme 2) has been found to be expressed in the nervous system (5) . The possibility of SARS-CoV-2 as a new neuropathogen has been postulated, but is as of yet unproven (5) . Infectious peripheral neuropathy is known to occur secondary to other viruses such as hepatitis C, human immunodeficiency virus (HIV), and I n P r e s s varicella zoster (6) . Similarly, immune-mediated neuropathies, such as Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP), are known to occur in the setting of viral infection (7) . Prolonged hospitalization can in itself lead to peripheral nerve pathology due to critical illness polyneuropathy (CIP) or secondary to prolonged patient positioning ( Figure 1 ) (3, (8) (9) . Over the past several months, cases of neurological complications in COVID-19 patients such as Guillain-Barre syndrome and prone positioningrelated peripheral neuropathy have been reported (1, 5, (10) (11) (12) (13) (14) (15) .

Advanced imaging techniques, including magnetic resonance (MR) neurography and high-resolution ultrasound (US), are well-established diagnostic tools for assessment of peripheral nerve injury (16) (17) (18) (19) (20) (21) (22) (23) (24) . Imaging of peripheral nerves in COVID-19 patients and survivors may characterize nerve pathology, may identify the site and severity of nerve damage, and may potentially elucidate mechanisms of injury (Table) . In collaboration with clinical counterparts in the fields of pulmonary and critical care medicine, physical medicine and rehabilitation, peripheral nerve surgery, and neurology, radiologists can aid medical decisionmaking and guide rehabilitative care for COVID-19 patients through optimized acquisition and accurate interpretation of advanced peripheral nerve imaging. To the best of our knowledge, there is no dedicated overview or publication of this topic to date. Thus, this review article aims to provide a comprehensive summary of the current knowledge of COVID-19, peripheral neuropathy, and peripheral nerve imaging.

Peripheral nerve anatomy can be visualized to the fascicular level on high resolution MR and ultrasound imaging. Peripheral nerves consist of individual nerve fibers (axons) that are each enclosed in a connective tissue sheath known as the endoneurium. Multiple axons are bundled together within a second connective tissue sheath termed the perineurium to form a nerve fascicle. Multiple fascicles are then enclosed in a fibrous sheath known as the I n P r e s s epineurium to form the peripheral nerve. An internal system of blood vessels within the epineurium, perineurium, and endoneurium provides oxygen and nutrients to the nerve (17, 25) .

High resolution MRI of peripheral nerves, known as MR neurography, can accurately depict both macro-and micro-structural changes in the nerve as well as secondary findings of peripheral nerve injury such as skeletal muscle denervation (18, 19, 24) . A normal peripheral nerve demonstrates uniform round or ovoid contour and expected continuous anatomic course on MRI, without evidence of discontinuity, displacement, focal thickening, focal narrowing, or mass lesion. Signal intensity of a normal peripheral nerve is isointense to slightly hyperintense to skeletal muscle on fluid sensitive sequences. The expected honeycomb appearance of the fascicular architecture of a normal nerve may be identified in the cross-sectional plane (17) (18) (19) .

Advancements in MR technology now allow for visualization of even small pure sensory peripheral nerves (18) .

Primary MR neurography findings of peripheral nerve injury include signal hyperintensity on fluid-sensitive sequences, change in nerve caliber, architectural distortion (loss of fascicular architecture), nerve discontinuity, mass effect/external compression, and perineural scarring (17, 19) . MR neurography findings can be correlated with the Seddon and Sunderland nerve injury classification schemes (26) . Signal hyperintensity of a peripheral nerve on MRI corresponds to Sunderland grade 1 or neuropraxia. Neuropraxia entails a short-term nerve conduction block resulting in clinical symptoms with expected recovery and good prognosis.

Imaging is typically not obtained in cases of neuropraxia. The additional MR findings of peripheral nerve thickening and fascicular enlargement indicate Sunderland grade 2 or axonotmesis. Axonotmesis involves axonal loss resulting in symptoms of nerve dysfunction, abnormal electrophysiologic studies, and potential muscle denervation (26) . In early reports, COVID-19 related peripheral nerve injury appear to be largely axonotmesis injuries (11, 27) .

Grade 3 injury or neurotmesis can be detected on MR neurography as a complete nerve gap as would be seen in the case of traumatic laceration (17, 19) .

Secondary MR neurography findings of peripheral nerve injury include signs of muscle denervation such as intramuscular edema-like signal in the acute/subacute setting and fatty infiltration and atrophy in the chronic setting. MR neurography readily depicts muscle changes in both superficial and deep locations and provides comprehensive evaluation of skeletal muscle due to the large field of view. Furthermore, MR neurography can detect skeletal muscle changes earlier than electromyography (EMG) -as soon as 4 days after injury (19) . In the setting of chronic peripheral nerve injury, MR is an ideal diagnostic tool for evaluation of extent of nerve injury and end-organ damage (17) .

Of note, muscle injury/myalgia is a common neuromuscular symptom associated with COVID-19 (28). Currently, there are no prospective original articles available regarding the differentiation between muscle abnormalities directly associated with COVID-19 and secondary muscle abnormalities due to COVID-19-related neuropathy. While there is no current evidence in the literature for specificity of MRI in terms of depicted muscle abnormalities in COVID-19 patients, MRI is generally well known to have high sensitivity for depiction of both muscle and nerve pathology. We believe that the hypothesis is justified that if muscle and nerve abnormalities are both seen on MRI, the findings likely represent COVID-19 associated nerve injury with secondary muscle damage when the muscle changes follow the specific innervation pattern of the affected nerve.

High resolution ultrasound can readily visualize peripheral nerves throughout the extremities and portions of the brachial plexus (16, 22, 23) . A normal peripheral nerve demonstrates uniform round or ovoid contour in the short axis with a characteristic honeycomb appearance reflecting intact fascicular architecture. Normal nerve fascicles are hypoechoic on ultrasound and surrounded by the hyperechoic epineurium. Both short and long axis imaging is I n P r e s s obtained to demonstrate normal nerve continuity and anatomic course. Advancements in ultrasound and transducer technology now allow for visualization of even small peripheral nerves (16, 22) .

Primary ultrasound findings of peripheral nerve injury include nerve enlargement, hypoechogenicity, and loss of fascicular architecture. Nerve discontinuity, mass effect/eternal compression, and perineural scarring are also readily identified on ultrasound. Secondary ultrasound findings of peripheral nerve injury include evidence of muscle denervation such as increased echogenicity and reduction of muscle size. Ultrasound can detect muscle denervation in the subacute timeframe, as soon as 2 weeks after nerve injury (16, 22) .

Advantages of ultrasound over MR neurography include cost benefit, portability, dynamic imaging, and contralateral side comparison. Ultrasound can also be performed in patients who are unable to tolerate MRI. Metallic artifact from hardware, which may be severely limiting on MRI despite metal artifact reduction techniques, is typically not problematic on ultrasound.

Disadvantages of ultrasound include potential lack of a suitable acoustic window and limitations of nerve visualization due to excessive body habitus or overlapping anatomical structures (i.e. the clavicle limits evaluation of a portion of the brachial plexus). MR neurography is also superior for comprehensive large field-of-view assessment of skeletal muscle (16, 22, 23) . In hospitalized patients with a COVID-19 positive test, ultrasound has the advantage of portability but the disadvantage of requiring close-contact of the sonographer or radiologist with the patient during scanning. Overall, both high resolution MR neurography and ultrasound are excellent non-invasive tools for assessment of peripheral nerve injury and have the ability to accurately localize pathology and determine extent of injury.

Imaging Techniques I n P r e s s MR neurography protocols generally include a combination of high resolution (2-3 mm section thickness) 2-dimensional (2D) and 3-dimensional (3D) anatomic sequences such as T1WI SE/T1WI FLAIR (T1 weighted spin-echo/T1 weighted fluid-attenuated inversion recovery) and fluid-sensitive sequences such as T2WIFS SE/SPAIR/STIR (T2 weighted fat saturated spin-echo/spectral attenuated inversion recovery/short-T1 inversion recovery) in multiple planes.

3D pulse sequences with multiplanar reconstructions are excellent for depicting peripheral nerves along their longitudinal course. MR neurography is typically performed on a 3-Tesla magnet for higher signal-to-noise ratio and better special resolution, unless there is a validated reason for imaging at a lower magnetic field strength such as metallic hardware in the region of interest (20, 21) . Diffusion weighted imaging (DWI) and diffusion tensor imaging (DTI) are advanced MR techniques that have yet to be widely utilized clinically for evaluation of peripheral nerves (17) . While there are no current universally-accepted practice guidelines for the use of intravenous contrast in MR neurography, prior literature has shown mild to no added benefit in the majority of cases (20) . In COVID-19 patients where peripheral nerve injury is suspected due to compression/stretch injury, intravenous contrast is not mandatory for diagnosis in the author's point of view. An exception is the utility of intravenous contrast for vascular suppression techniques that have been described for MRI of the brachial plexus (20) . MR neurography protocols should be tailored on a case-by-case basis in COVID-19 patients to include the appropriate field of view of the nerve(s) in question and relevant skeletal muscle.

High resolution ultrasound of peripheral nerves should be performed with highfrequency, linear-array transducers (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Lower frequency transducers may be necessary for larger patients and/or deeper nerves (16, 22) . Both short and long axis imaging of the peripheral nerve should be obtained as well as imaging of relevant skeletal muscle.

Dynamic imaging (i.e. of the ulnar nerve at the cubital tunnel) and comparison to the contralateral side may be indicated. In some instances, preliminary point-of-care ultrasound may be performed by clinicians in the physician's office with portable ultrasound machines.

Radiologists, however, should utilize high-end ultrasound machines with state-of-the-art scanner and transducer designs in order to obtain high resolution imaging of even small peripheral nerves. As ultrasound is highly operator-dependent, peripheral nerve sonography should be interpreted by radiologists with specific training in nerve ultrasound. In some settings, peripheral nerve ultrasound may be limited or non-existent in which case referral to advanced imaging facilities and/or MRI should be considered.

While many patients who sustain peripheral nerve injury during their COVID-19 illness will present to imaging centers in a delayed fashion after COVID-19 test results become 

Post-infectious inflammatory peripheral nerve injury is thought to occur secondary to immune-mediated mechanisms and can occur in the setting of multiple different viruses (6, 7).

Post-infectious inflammatory peripheral nerve injury secondary to SARS-CoV-2 infection is therefore a theoretical differential consideration, and indeed several cases of COVID-19 patients presenting with peripheral neuropathy and Guillain-Barre syndrome have been reported in the clinical literature (31, 32) . The rarity of thus far reported post-COVID-19 possibly immunemediated cases should be considered, however, when interpreting imaging of peripheral nerves I n P r e s s (1) . Of note, imaging features of post-infectious inflammatory peripheral nerve injury are not specific to the infectious agent and therefore correlation with viral testing history is advised in COVID-19 patients.

Guillain-Barre syndrome is an immune-mediated neuropathy that is the most common cause of acute flaccid paralysis throughout the world (33) . Multiple case reports of Guillain-Barre Syndrome following COVID-19 infection have been reported in recent months (5, 13, 26) .

Patients with Guillain-Barre Syndrome typically demonstrate symptoms a few weeks following infection (33) . Acute inflammatory demyelinating polyneuropathy (AIDP) is a common subtype of Guillain-Barre in COVID-19 patients. Clinical features of AIDP includes numbness and tingling in the hands and feet followed by progressive weakness (33) . Generally, AIDP has a good prognosis. Imaging findings include signal hyperintensity, enlargement, and mild to moderate contrast enhancement of the cauda equina, nerve roots/plexus, and peripheral nerves (26) . Contrast enhancement of the cauda equina is a typical MR finding of Guillain-Barre Syndrome. Albuminocytologic dissociation is seen in the CSF in the majority of Guillain-Barre Syndrome patients (33) . Immunotherapy (steroids, plasmapheresis, or intravenous gammaglobulin) accelerates recovery. Functionally significant residual deficits are observed in approximately 15% of Guillain-Barre Syndrome patients (33) .

Chronic inflammatory demyelinating polyneuropathy is a chronic analog to Guillain-Barre syndrome with a poor prognosis. Chronic symptoms (greater than 8 weeks) of muscle weakness, sensory loss, and areflexia are presenting features, typically with an insidious onset.

Albuminocytologic dissociation with high cerebrospinal fluid protein is found on lumbar puncture (26, 33) . CIDP is more common in the lower extremity (17, 26) . Imaging findings are similar to that of AIDP and include focal or diffuse enlargement and signal hyperintensity of the peripheral nerves, nerve roots/plexus, and cauda equina. Contrast enhancement is usually not present.

As with other acquired neuropathies, asymmetric nerve abnormalities can be seen (17, 26) .

Nerve root hypertrophy in the lumber spine may result in crowding and entrapment, and patients I n P r e s s may demonstrate symptoms of cauda equina dysfunction and lumbar stenosis (33) . Treatment with immunotherapy has been shown to be beneficial for most patients with CIDP (33).

Parsonage-Turner syndrome, first described in the 1940s, is a stress-mediated acute brachial plexitis that can occur after a number of conditions including trauma, pregnancy, and viral infections and hence could theoretically occur in the setting of COVID-19 (8, 25) . Clinical presentation of Parsonage-Turner Syndrome includes delayed-onset severe shoulder pain that develops rapidly and can result in muscle atrophy (8, 25) . Parsonage-Turner Syndrome is more Syndrome is one of exclusion and the rarity of thus far reported post-COVID-19 immunemediated cases (aside from Guillan-Barre syndrome and its variants) should be considered (8) .

As Parsonage-Turner Syndrome is self-limiting, treatment is conservative (21).

Peripheral nerve injury is a known potential complication of patient positioning that has been well reported in the surgical and anesthesia literature (8, 25, 36) . Recently, peripheral nerve injury in COVID-19 patients and survivors has been described in the literature following the use of prone positioning for COVID-19-related ARDS (9, 11, 27) . Prone positioning is an evidenced-based therapy for optimization of oxygenation in patients with ARDS that has been I n P r e s s applied to hospitalized COVID-19 patients throughout the world (37) (38) (39) (40) (41) (42) (43) (44) (45) . While direct causality between prone positioning and peripheral nerve injury is difficult to prove, the timing of onset of clinical symptoms and the plethora of prior surgical literature on positioning peripheral nerve injury is highly suggestive of a correlation (Figure 3 and external equipment (i.e. padding, blood pressure cuff) influence the location and extent of nerve injury (8) . Brachial plexus positioning injury can be due to compression between the I n P r e s s clavicle and the ribs, compression at the level of the scalene muscles, or stretching across the humeral head (25) . Ulnar neuropathy can occur in the setting of external compression at the level of the cubital tunnel (25) . Male gender is thought to be a risk factor for ulnar neuropathy due to anatomical differences between men and women at the level of the cubital tunnel (25) .

Other individual anatomic variants (i.e. cervical ribs, anconeus epitrochlearis) may also predispose patients to positioning peripheral nerve injury (8) .

Prone positioning can less commonly result in peripheral nerve injuries involving the radial, median, and common peroneal (fibular) nerves (Figures 6 and 7) . Compression of the radial nerve can occur from external factors along the posterior aspect of the arm at the level of the spiral groove (8, 25) . Similarly, external factors may cause compression of the proximal median nerve within the upper arm (8) . Wrist hyperextension for prolonged periods can lead to distal median nerve injury at the level of the wrist (25) . External compression and stretch injury of the common peroneal nerve can occur at the level of the fibular head due to suboptimal knee positioning (8) . Lateral femoral cutaneous nerve neuropathy, also known as meralgia paresthetica, can uncommonly occur in the setting of prone position with inadequately padded bolsters that compress the nerve at the level of the thigh (8, 36) . Isolated positioning-related axillary nerve injury is rare but has been reported in association with the prone position ( Figure   8 ) (8) .

Positioning-related peripheral nerve injury typically results in neuropraxia or axonotmesis (36) . Corresponding MR neurography findings include nerve signal hyperintensity, thickening, and in some cases fascicular enlargement (Figures 3-5) (17) . High resolution ultrasound findings include nerve hypoechogenicity, thickening, and in some cases fascicular enlargement 

Distal symmetric polyneuropathy is the most common subtype of peripheral neuropathy and can be due to a variety of causes including diabetes, nutritional deficiencies, toxic etiologies, and infectious/inflammatory conditions (47) . In diabetic polyneuropathy, diffuse bilateral signal hyperintensity of peripheral nerves can be seen (17) . As many COVID-19 patients with neuromuscular symptoms may have underlying conditions such as diabetes, preexisting distal symmetric polyneuropathy should be accounted for when evaluating imaging of peripheral nerve injury (Figure 9 ).

Critical illness polyneuropathy is a distal symmetric polyneuropathy associated with prolonged hospital course typically within the intensive care unit. Clinical symptoms of muscle weakness are most pronounced in the lower extremities and may be severe with positive associated electrophysiological findings (48) . While imaging is typically not obtained in critical illness polyneuropathy, MRI may demonstrate diffuse symmetric nerve signal hyperintensity and associated muscle denervation edema ( Figure 10 ). Critical illness myopathy is a separate entity from critical illness polyneuropathy that presents with muscle weakness in patients with a prolonged hospital course typically within the intensive care unit. Critical illness myopathy represents a primary myopathy (ie. muscle necrosis) and hence the pattern of intramuscular edema-like signal is not expected to follow the innervation distribution of any particular peripheral nerve (48) . While imaging is typically not obtained in critical illness myopathy, MRI may demonstrate multi-focal intramuscular edema-like signal in the acute setting and fatty infiltration and atrophy in the chronic setting.

Nerve entrapment results in focal compression of a peripheral nerve due to an adjacent space-occupying lesion (hematoma, tumor, bony callous) and/or in the setting of an anatomical tunnel (17, 49) . Nerve entrapment can potentially develop in COVID-19 patients during their hospital course secondary to a large hematoma or other drainable fluid collection. Emerging research suggests that SARS-CoV-2 may predispose patients to thrombotic complications (50) (51) . As many COVID-19 patients may be treated with anti-coagulation medications during their hospital course, the potential for development of soft tissue hematoma should be considered ( Figure 11 ). Ultrasound and MRI can ready diagnose hematomas and assess for mass effect on adjacent peripheral nerves (Figures 12 and 13 ). Ultrasound features of nerve entrapment include hypoechogenecity, disruption of fascicular architecture, and caliber change at the site of entrapment. MR neurography features of nerve entrapment include nerve signal hyperintensity and caliber change at the site of entrapment (17) .

Depending on location and extent of nerve damage, peripheral nerve injury can cause patient morbidity and affect quality of life in COVID-19 survivors (1) (2) (3) (4) (5) (11) (12) (13) (14) (15) . The reference standard for neuropathy diagnosis has traditionally been electrophysiology; however, in more recent years, imaging has played a greater role in evaluation of peripheral nerve injury.

Peripheral nerve injury can serve as a non-invasive alternative or as an adjuvant diagnostic test to electromyography and nerve conduction studies for localization and evaluation of peripheral nerve injury. Limitations of electrophysiology include false negative results in the setting of neurapraxia, invasive nature and physical discomfort to the patients, and difficulty in precise localization of nerve pathology (17) . In many cases, imaging can serve as a complement tool to electrophysiology for evaluation of peripheral nerve injury, allowing for precise localization of nerve pathology and early comprehensive assessment of associated muscle damage. Studies have shown that imaging of peripheral nerves impacts clinical decision-making and guides therapeutic plans (52) (53) . Imaging of peripheral nerves, however, remains underutilized (53) .

During these unprecedented times where healthcare practices have been modified by the COVID-19 pandemic and social distancing has become the norm, radiologists must reach out to clinical counterparts to discuss imaging options and collaborative patient care.

Treatment options for peripheral nerve injury include conservative measures such as pain medications and physical therapy, steroid injections (potentially image guided with ultrasound), and surgery in more severe cases (8, 36) . Immunotherapy may be helpful for postinfectious inflammatory peripheral nerve injury (33) . Surgical options for peripheral nerve injury Management of peripheral nerve injury in COVID-19 survivors therefore should be included in future COVID-19-specific rehabilitation programs, with appropriate integration of peripheral nerve imaging and potential follow-up imaging to aid clinical decision-making.

The global pandemic of COVID-19 has challenged the healthcare system and many questions remain in regards to our understanding of the virus, its sequelae, and long-term outcomes. Mechanisms of peripheral nerve injury in COVID-19 patients may be multifactorial including complications of systemic disease, direct neuro-invasion, and autoimmune response.

Further research is necessary to elucidate pathophysiology of peripheral nerve injury in COVID-I n P r e s s relationship with prone positioning in the setting of COVID-19-related ARDS. Along those lines, further research is needed to determine if COVID-19 patients are at higher risk for peripheral nerve injury -potentially due to co-morbidities such as diabetes, obesity, and older age or plausibly secondary to a virus-induced state of hyper-inflammation. c. d. I n P r e s s I n P r e s s c. d. 

COVID-19: A Global Threat to the Nervous System

COVID-19 Pandemic: A Neurological Perspective

Neurological manifestations and implications of COVID-19 pandemic

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review

Infectious neuropathies

Diseases of the peripheral nerves

Intraoperative positioning nerve injuries

The Down Side of Prone Positioning: The Case of a COVID-19 Survivor

Guillain-Barré syndrome related to COVID-19 infection

Injury-Prone: Peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Guillain Barre syndrome associated with COVID-19 infection: A case report

Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis

Guillain-Barré syndrome following COVID-19: new infection, old complication?

US of the Peripheral Nerves of the Upper Extremity: A Landmark Approach

Magnetic resonance neurography: current perspectives and literature review

Pins and Needles From Fingers to Toes: High-Resolution MRI of Peripheral Sensory Mononeuropathies

Magnetic resonance neurography of traumatic pediatric peripheral nerve injury: beyond birth-related brachial palsy

With or without? A retrospective analysis of intravenous contrast utility in magnetic resonance neurography

US of the Peripheral Nerves of the Lower Extremity: A Landmark Approach

Ultrasound of the Brachial Plexus

MRN) of the long thoracic nerve: retrospective review of clinical findings and imaging results at our institution over 4 years

Positioning patients for spine surgery: Avoiding uncommon positionrelated complications

Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions

Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis

Diagnostic Ultrasound Services During the Coronavirus Disease (COVID-19) Pandemic

COVID 19 infection presenting as motor peripheral neuropathy

Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?

Peripheral neuropathy: clinical and electrophysiological considerations

MRI bullseye sign: An indicator of peripheral nerve constriction in parsonage-turner syndrome

Complications associated with prone positioning in elective spinal surgery

Prone Positioning in Acute Respiratory Distress Syndrome

Prone positioning in severe acute respiratory distress syndrome

Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis

Treatment of ARDS With Prone Positioning

Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study

Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure

Using the prone position could help to combat the development of fast hypoxia in some patients with COVID-19

Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience

Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure

Brachial plexopathy after prone positioning

Distal Symmetric Polyneuropathy: A Review

Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis

MR Imaging of Entrapment Neuropathies of the Lower Extremity

Thrombosis risk associated with COVID-19 infection. A scoping review

Lip GYH. I n P r e s s COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review

Clinical impact of magnetic resonance neurography in patients with brachial plexus neuropathies

The Incremental Value of Magnetic Resonance Neurography for the Neurosurgeon: Review of the Literature

The War on COVID-19 Pandemic: Role of Rehabilitation Professionals and Hospitals

Considerations for Postacute Rehabilitation for Survivors of COVID-19

I n P r e s s